HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-MAR-12 4E26 TITLE BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 432-768; COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PFASTBAC KEYWDS KINASE, INHIBITOR, ONCOPROTEIN, MELANOMA, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.QIN,P.XIE,C.VENTOCILLA,G.ZHOU,A.VULTUR,Q.CHEN,M.HERLYN,J.WINKLER, AUTHOR 2 R.MARMORSTEIN REVDAT 4 28-FEB-24 4E26 1 REMARK SEQADV REVDAT 3 09-JAN-13 4E26 1 ATOM DBREF HELIX REMARK REVDAT 3 2 1 SEQADV SHEET SITE REVDAT 2 27-JUN-12 4E26 1 JRNL REVDAT 1 09-MAY-12 4E26 0 JRNL AUTH J.QIN,P.XIE,C.VENTOCILLA,G.ZHOU,A.VULTUR,Q.CHEN,Q.LIU, JRNL AUTH 2 M.HERLYN,J.WINKLER,R.MARMORSTEIN JRNL TITL IDENTIFICATION OF A NOVEL FAMILY OF BRAF(V600E) INHIBITORS. JRNL REF J.MED.CHEM. V. 55 5220 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22537109 JRNL DOI 10.1021/JM3004416 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23280 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2127 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4267 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 76 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4E26 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000071074. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03317 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED REMARK 200 SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24752 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM MAGNESIUM ACETATE TETRAHYDRATE, REMARK 280 100 MM SODIUM CACODYLATE TRIHYDRATE (PH 6.5), AND 20% REMARK 280 POLYETHYLENE GLYCOL 8000, MICROBATCH, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.73600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.13850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.13850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.86800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.13850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.13850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 122.60400 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.13850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.13850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.86800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.13850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.13850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 122.60400 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.73600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 420 REMARK 465 ASP A 421 REMARK 465 ARG A 422 REMARK 465 GLY A 423 REMARK 465 SER A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 GLY A 431 REMARK 465 SER A 432 REMARK 465 GLU A 433 REMARK 465 ASP A 434 REMARK 465 ARG A 435 REMARK 465 ASN A 436 REMARK 465 ARG A 437 REMARK 465 MET A 438 REMARK 465 LYS A 439 REMARK 465 THR A 440 REMARK 465 LEU A 441 REMARK 465 GLY A 442 REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 ILE A 724 REMARK 465 HIS A 725 REMARK 465 ARG A 726 REMARK 465 MET B 420 REMARK 465 ASP B 421 REMARK 465 ARG B 422 REMARK 465 GLY B 423 REMARK 465 SER B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 GLY B 431 REMARK 465 SER B 432 REMARK 465 GLU B 433 REMARK 465 ASP B 434 REMARK 465 ARG B 435 REMARK 465 ASN B 436 REMARK 465 ARG B 437 REMARK 465 MET B 438 REMARK 465 LYS B 439 REMARK 465 THR B 440 REMARK 465 LEU B 441 REMARK 465 GLY B 442 REMARK 465 ARG B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 LYS B 723 REMARK 465 ILE B 724 REMARK 465 HIS B 725 REMARK 465 ARG B 726 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N SER B 536 CAA 734 B 801 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 449 -179.06 -51.68 REMARK 500 GLN A 461 136.49 -37.49 REMARK 500 SER A 465 -153.87 -124.94 REMARK 500 PHE A 468 40.26 -99.34 REMARK 500 TRP A 476 93.62 -167.41 REMARK 500 VAL A 487 151.57 -41.21 REMARK 500 ARG A 509 82.18 -152.43 REMARK 500 ASP A 576 37.69 -154.04 REMARK 500 GLU A 586 18.16 58.28 REMARK 500 LEU A 588 -50.91 -128.10 REMARK 500 ASP A 594 82.31 45.29 REMARK 500 SER A 602 50.75 70.91 REMARK 500 GLU A 611 17.25 170.14 REMARK 500 LEU A 613 133.94 73.86 REMARK 500 SER A 614 70.90 176.82 REMARK 500 SER A 616 76.55 -102.00 REMARK 500 GLN A 628 -73.49 -79.56 REMARK 500 ASP A 629 161.14 -38.53 REMARK 500 ASN A 631 70.63 68.56 REMARK 500 ARG A 682 150.47 -40.24 REMARK 500 SER B 465 66.45 -158.38 REMARK 500 SER B 467 -97.65 42.11 REMARK 500 TRP B 476 91.96 -172.24 REMARK 500 PRO B 490 0.73 -50.61 REMARK 500 THR B 491 -173.20 48.08 REMARK 500 LYS B 522 -124.89 -10.26 REMARK 500 GLU B 545 63.27 36.70 REMARK 500 ASP B 576 33.36 -165.26 REMARK 500 ASP B 587 2.26 58.18 REMARK 500 THR B 589 110.01 104.20 REMARK 500 ASP B 594 96.15 46.52 REMARK 500 PHE B 595 -138.63 -111.58 REMARK 500 LYS B 601 169.03 61.64 REMARK 500 SER B 616 37.84 -144.56 REMARK 500 ASP B 629 -26.71 -140.24 REMARK 500 LYS B 630 -3.47 75.37 REMARK 500 ASN B 631 47.97 -148.69 REMARK 500 ARG B 701 -71.36 -39.09 REMARK 500 ASP B 702 -0.25 -54.72 REMARK 500 SER B 720 70.51 -108.41 REMARK 500 LEU B 721 -52.36 -126.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 734 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 734 B 801 DBREF 4E26 A 432 726 UNP P15056 BRAF_HUMAN 432 726 DBREF 4E26 B 432 726 UNP P15056 BRAF_HUMAN 432 726 SEQADV 4E26 MET A 420 UNP P15056 EXPRESSION TAG SEQADV 4E26 ASP A 421 UNP P15056 EXPRESSION TAG SEQADV 4E26 ARG A 422 UNP P15056 EXPRESSION TAG SEQADV 4E26 GLY A 423 UNP P15056 EXPRESSION TAG SEQADV 4E26 SER A 424 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 425 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 426 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 427 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 4E26 GLY A 431 UNP P15056 EXPRESSION TAG SEQADV 4E26 MET B 420 UNP P15056 EXPRESSION TAG SEQADV 4E26 ASP B 421 UNP P15056 EXPRESSION TAG SEQADV 4E26 ARG B 422 UNP P15056 EXPRESSION TAG SEQADV 4E26 GLY B 423 UNP P15056 EXPRESSION TAG SEQADV 4E26 SER B 424 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 425 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 426 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 427 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 4E26 HIS B 430 UNP P15056 EXPRESSION TAG SEQADV 4E26 GLY B 431 UNP P15056 EXPRESSION TAG SEQRES 1 A 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 A 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 A 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 A 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 A 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 A 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 A 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 A 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 A 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 A 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 A 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 A 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 A 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 A 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 A 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 A 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 A 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 A 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 A 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 A 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 A 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 A 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 A 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 A 307 ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 B 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 B 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 B 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 B 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 B 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 B 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 B 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 B 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 B 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 B 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 B 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 B 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 B 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 B 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 B 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 B 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 B 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 B 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 B 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 B 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 B 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 B 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 B 307 ARG SER LEU PRO LYS ILE HIS ARG HET 734 A 801 25 HET 734 B 801 25 HETNAM 734 5-CHLORO-7-[(R)-FURAN-2-YL(PYRIDIN-2-YLAMINO) HETNAM 2 734 METHYL]QUINOLIN-8-OL FORMUL 3 734 2(C19 H14 CL N3 O2) FORMUL 5 HOH *76(H2 O) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 LEU A 537 ILE A 543 1 7 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 LYS A 578 ASN A 580 5 3 HELIX 5 5 SER A 616 MET A 620 5 5 HELIX 6 6 ALA A 621 MET A 627 1 7 HELIX 7 7 SER A 634 GLY A 652 1 19 HELIX 8 8 ASN A 661 GLY A 672 1 12 HELIX 9 9 ASP A 677 VAL A 681 5 5 HELIX 10 10 PRO A 686 LEU A 697 1 12 HELIX 11 11 LYS A 700 ARG A 704 5 5 HELIX 12 12 LEU A 706 SER A 720 1 15 HELIX 13 13 GLN B 493 ARG B 506 1 14 HELIX 14 14 LEU B 537 ILE B 543 1 7 HELIX 15 15 GLU B 549 LYS B 570 1 22 HELIX 16 16 SER B 616 MET B 620 5 5 HELIX 17 17 ALA B 621 MET B 627 1 7 HELIX 18 18 SER B 634 GLY B 652 1 19 HELIX 19 19 ASN B 661 ARG B 671 1 11 HELIX 20 20 ASP B 677 VAL B 681 5 5 HELIX 21 21 PRO B 686 LEU B 697 1 12 HELIX 22 22 LYS B 700 ARG B 704 5 5 HELIX 23 23 LEU B 706 SER B 720 1 15 SHEET 1 A 4 THR A 470 TYR A 472 0 SHEET 2 A 4 VAL A 480 MET A 484 -1 O MET A 484 N THR A 470 SHEET 3 A 4 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 4 A 4 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 2 ILE A 572 ILE A 573 0 SHEET 2 C 2 THR A 599 VAL A 600 -1 O THR A 599 N ILE A 573 SHEET 1 D 5 THR B 458 GLY B 464 0 SHEET 2 D 5 THR B 470 LYS B 475 -1 O LYS B 475 N THR B 458 SHEET 3 D 5 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 4 D 5 ALA B 526 GLN B 530 -1 O THR B 529 N ALA B 481 SHEET 5 D 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 E 3 GLY B 534 SER B 536 0 SHEET 2 E 3 ILE B 582 HIS B 585 -1 O LEU B 584 N SER B 535 SHEET 3 E 3 VAL B 590 ILE B 592 -1 O LYS B 591 N PHE B 583 SHEET 1 F 2 ILE B 572 ILE B 573 0 SHEET 2 F 2 THR B 599 VAL B 600 -1 O THR B 599 N ILE B 573 SITE 1 AC1 7 ALA A 481 LEU A 514 GLN A 530 TRP A 531 SITE 2 AC1 7 CYS A 532 SER A 536 PHE A 583 SITE 1 AC2 10 ILE B 463 GLY B 464 ALA B 481 GLN B 530 SITE 2 AC2 10 TRP B 531 CYS B 532 SER B 535 SER B 536 SITE 3 AC2 10 HIS B 539 PHE B 583 CRYST1 94.277 94.277 163.472 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010607 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010607 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006117 0.00000